Tagi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TAGI, and what generic and branded alternatives to TAGI drugs are available?
TAGI has four approved drugs.
Drugs and US Patents for Tagi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tagi | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 212857-001 | Nov 23, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Tagi | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209599-002 | Nov 12, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Tagi | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 215615-001 | Oct 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Tagi | CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 209597-002 | Mar 9, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Tagi | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 212857-003 | Nov 23, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Tagi | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 215615-002 | Oct 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.